BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6295997)

  • 1. Human cerebrospinal fluid pharmacokinetics and treatment of bacterial meningitis with ceftizoxime.
    Cable D; Edralin G; Overturf GD
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():121-7. PubMed ID: 6295997
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of bacterial meningitis with ceftizoxime.
    Overturf GD; Cable DC; Forthal DN; Shikuma C
    Antimicrob Agents Chemother; 1984 Feb; 25(2):258-62. PubMed ID: 6324670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Penetration of ceftizoxime (FK 749) into the cerebrospinal fluid (author's transl)].
    Ruf B
    Infection; 1982; 10(2):76-80. PubMed ID: 6284650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations of cefotaxime and the desacetyl metabolite in serum and CSF of patients with meningitis.
    Humbert G; Leroy A; Nair SR; Cherubin CE
    J Antimicrob Chemother; 1984 May; 13(5):487-94. PubMed ID: 6330021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in children with meningitis treated with high-dosage cefotaxime.
    Friedland IR; Klugman KP
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1888-91. PubMed ID: 9303379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of purulent meningitis with ceftriaxone].
    Guggenbichler JP; Parth J
    Wien Med Wochenschr Suppl; 1985; 87():12-6. PubMed ID: 3856970
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics of ceftriaxone in pediatric patients with meningitis.
    Steele RW; Eyre LB; Bradsher RW; Weinfeld RE; Patel IH; Spicehandler J
    Antimicrob Agents Chemother; 1983 Feb; 23(2):191-4. PubMed ID: 6301362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cefmenoxime diffusion into cerebrospinal fluid during human purulent meningitis].
    Stahl JP; Croize J; Bru JP; Pegourie B; Blanc-Jouvan F; Bryskier A; Micoud M
    Pathol Biol (Paris); 1985 May; 33(5):365-7. PubMed ID: 3897967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics and clinical effects of ceftizoxime in pediatric field (author's transl)].
    Jpn J Antibiot; 1982 Jan; 35(1):113-36. PubMed ID: 6279904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and cerebrospinal fluid bactericidal activity of ceftriaxone in the treatment of pediatric patients with bacterial meningitis.
    Del Rio M; McCracken GH; Nelson JD; Chrane D; Shelton S
    Antimicrob Agents Chemother; 1982 Oct; 22(4):622-7. PubMed ID: 6295262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion of ceftriaxone into the cerebrospinal fluid of adults.
    Chandrasekar PH; Rolston KV; Smith BR; LeFrock JL
    J Antimicrob Chemother; 1984 Oct; 14(4):427-30. PubMed ID: 6094424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fundamental and clinical studies in pediatric field on ceftizoxime (author's transl)].
    Nakazawa S; Sato H; Nakazawa SI; Niino K; Hirama Y; Narita A; Chikaoka H; Oka S
    Jpn J Antibiot; 1982 Jan; 35(1):33-46. PubMed ID: 6279912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics of ceftriaxone in blood and ventricular cerebrospinal fluid in children with ventriculitis].
    Prado V; Arancibia A; Aguirre X
    Bol Med Hosp Infant Mex; 1984 Jun; 41(6):313-7. PubMed ID: 6089848
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of ceftriaxone with standard therapy for bacterial meningitis.
    Steele RW; Bradsher RW
    J Pediatr; 1983 Jul; 103(1):138-41. PubMed ID: 6306192
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics and clinical evaluation of cefotaxime in children suffering with purulent meningitis.
    Bégué P; Floret D; Mallet E; Raynaud EJ; Safran C; Sarlangues J; Teyssier G
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():161-5. PubMed ID: 6094436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of ceftriaxone in neonates and infants with meningitis.
    Martin E; Koup JR; Paravicini U; Stoeckel K
    J Pediatr; 1984 Sep; 105(3):475-81. PubMed ID: 6088747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefotaxime and desacetylcefotaxime pharmacokinetics in infants and children with meningitis.
    Trang JM; Jacobs RF; Kearns GL; Brown AL; Wells TG; Underwood FL; Kluza RB
    Antimicrob Agents Chemother; 1985 Dec; 28(6):791-5. PubMed ID: 4083862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-blind controlled study of ceftizoxime and cefamandole in the treatment of community-acquired pneumonia.
    Grieco MM; Lange M; Daniels JA; Den M; Amaram N; Kornfeld H
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():223-5. PubMed ID: 6296010
    [No Abstract]   [Full Text] [Related]  

  • 19. Single-dose plasma and cerebrospinal fluid pharmacokinetics of ceftriaxone in infants and children.
    Reed MD; Rekate HL; Aronoff SC; Myers CM; Blumer JL
    Clin Pharm; 1983; 2(6):558-63. PubMed ID: 6317277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with ceftizoxime: an overall summary of clinical trials in Japan.
    Shimada J; Shimizu K
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():311-26. PubMed ID: 6296026
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.